Literature DB >> 12887893

Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.

Shen-Hsi Yang1, Ellis Jaffray, Ron T Hay, Andrew D Sharrocks.   

Abstract

The ETS domain transcription factor Elk-1 is a direct target of the MAP kinase pathways. Phosphorylation of the Elk-1 transcriptional activation domain by MAP kinases triggers its activation. However, Elk-1 also contains two domains with repressive activities. One of these, the R motif, appears to function by suppressing the activity of the activation domain. Here, we demonstrate that SUMO modification of the R motif is required for this repressive activity. A dynamic interplay exists between the activating ERK MAP kinase pathway and the repressive SUMO pathway. ERK pathway activation leads to both phosphorylation of Elk-1 and loss of SUMO conjugation and, hence, to the loss of the repressive activity of the R motif. Thus, the reciprocal regulation of the activation and repressive activities are coupled by MAP kinase modification of Elk-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887893     DOI: 10.1016/s1097-2765(03)00265-x

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  95 in total

1.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

2.  CD2AP regulates SUMOylation of CIN85 in podocytes.

Authors:  Irini Tossidou; Rainer Niedenthal; Malte Klaus; Beina Teng; Kirstin Worthmann; Benjamin L King; Kevin J Peterson; Hermann Haller; Mario Schiffer
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

3.  Coordinated regulation of transcription factor Bcl11b activity in thymocytes by the mitogen-activated protein kinase (MAPK) pathways and protein sumoylation.

Authors:  Ling-juan Zhang; Walter K Vogel; Xiao Liu; Acharawan Topark-Ngarm; Brian L Arbogast; Claudia S Maier; Theresa M Filtz; Mark Leid
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

4.  cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation.

Authors:  ChungSik Choi; Hassan Sellak; Felricia M Brown; Thomas M Lincoln
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

5.  SUMO functions in constitutive transcription and during activation of inducible genes in yeast.

Authors:  Emanuel Rosonina; Sarah M Duncan; James L Manley
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

6.  Ikaros SUMOylation: switching out of repression.

Authors:  Pablo Gómez-del Arco; Joseph Koipally; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  PDSM, a motif for phosphorylation-dependent SUMO modification.

Authors:  Ville Hietakangas; Julius Anckar; Henri A Blomster; Mitsuaki Fujimoto; Jorma J Palvimo; Akira Nakai; Lea Sistonen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

8.  SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex.

Authors:  Zihua Gong; Marc Brackertz; Rainer Renkawitz
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

9.  MafG sumoylation is required for active transcriptional repression.

Authors:  Hozumi Motohashi; Fumiki Katsuoka; Chika Miyoshi; Yasuhiro Uchimura; Hisato Saitoh; Claire Francastel; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

10.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.